ENSG00000084754


Homo sapiens

Features
Gene ID: ENSG00000084754
  
Biological name :HADHA
  
Synonyms : HADHA / hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha / P40939
  
Possible biological names infered from orthology :
  
Species: Homo sapiens
  
Chr. number: 2
Strand: -1
Band: p23.3
Gene start: 26190635
Gene end: 26244726
  
Corresponding Affymetrix probe sets: 208629_s_at (Human Genome U133 Plus 2.0 Array)   208630_at (Human Genome U133 Plus 2.0 Array)   208631_s_at (Human Genome U133 Plus 2.0 Array)   
  
Cross references: Ensembl peptide - ENSP00000495353
Ensembl peptide - ENSP00000496185
Ensembl peptide - ENSP00000495560
Ensembl peptide - ENSP00000370023
Ensembl peptide - ENSP00000438039
Ensembl peptide - ENSP00000493761
Ensembl peptide - ENSP00000493880
Ensembl peptide - ENSP00000493956
Ensembl peptide - ENSP00000493996
NCBI entrez gene - 3030     See in Manteia.
OMIM - 600890
RefSeq - NM_000182
RefSeq Peptide - NP_000173
swissprot - E9KL44
swissprot - H0YFD6
swissprot - P40939
Ensembl - ENSG00000084754
  
Related genetic diseases (OMIM): 609015 - Trifunctional protein deficiency, 609015
  609016 - Fatty liver, acute, of pregnancy, 609016
See expression report in BioGPS
See gene description in Wikigenes
See gene description in GeneCards
See co-cited genes in PubMed


Ortholog prediction (from Ensembl)
Ortholog nameID Species
 hadhaaENSDARG00000057128Danio rerio
 hadhabENSDARG00000060594Danio rerio
 HADHAENSGALG00000016536Gallus gallus
 HadhaENSMUSG00000025745Mus musculus


Paralog prediction (from Ensembl)
Paralog nameIDSimilarity(%)
EHHADH / Q08426 / enoyl-CoA hydratase and 3-hydroxyacyl CoA dehydrogenaseENSG0000011379027
HADH / Q16836 / hydroxyacyl-CoA dehydrogenaseENSG0000013879612


Protein motifs (from Interpro)
Interpro ID Name
 IPR001753  Enoyl-CoA hydratase/isomerase
 IPR006108  3-hydroxyacyl-CoA dehydrogenase, C-terminal
 IPR006176  3-hydroxyacyl-CoA dehydrogenase, NAD binding
 IPR006180  3-hydroxyacyl-CoA dehydrogenase, conserved site
 IPR008927  6-phosphogluconate dehydrogenase-like, C-terminal domain superfamily
 IPR012803  Fatty acid oxidation complex, alpha subunit, mitochondrial
 IPR013328  6-phosphogluconate dehydrogenase, domain 2
 IPR018376  Enoyl-CoA hydratase/isomerase, conserved site
 IPR029045  ClpP/crotonase-like domain superfamily
 IPR036291  NAD(P)-binding domain superfamily


Gene Ontology (GO)
TypeGO IDTermEv.Code
 biological_processGO:0006629 lipid metabolic process IEA
 biological_processGO:0006631 fatty acid metabolic process IEA
 biological_processGO:0006635 fatty acid beta-oxidation IEA
 biological_processGO:0008152 metabolic process IEA
 biological_processGO:0032868 response to insulin IEA
 biological_processGO:0035965 cardiolipin acyl-chain remodeling TAS
 biological_processGO:0042493 response to drug IEA
 biological_processGO:0055114 oxidation-reduction process IEA
 cellular_componentGO:0005739 mitochondrion IEA
 cellular_componentGO:0005743 mitochondrial inner membrane TAS
 cellular_componentGO:0016507 mitochondrial fatty acid beta-oxidation multienzyme complex IEA
 cellular_componentGO:0042645 mitochondrial nucleoid IDA
 molecular_functionGO:0000062 fatty-acyl-CoA binding IEA
 molecular_functionGO:0003824 catalytic activity IEA
 molecular_functionGO:0003857 3-hydroxyacyl-CoA dehydrogenase activity IEA
 molecular_functionGO:0003985 acetyl-CoA C-acetyltransferase activity TAS
 molecular_functionGO:0003988 acetyl-CoA C-acyltransferase activity IEA
 molecular_functionGO:0004300 enoyl-CoA hydratase activity IEA
 molecular_functionGO:0005515 protein binding IPI
 molecular_functionGO:0016491 oxidoreductase activity IEA
 molecular_functionGO:0016508 long-chain-enoyl-CoA hydratase activity IEA
 molecular_functionGO:0016509 long-chain-3-hydroxyacyl-CoA dehydrogenase activity IEA
 molecular_functionGO:0016829 lyase activity IEA
 molecular_functionGO:0051287 NAD binding IEA


Pathways (from Reactome)
Pathway description
Acyl chain remodeling of CL
Beta oxidation of myristoyl-CoA to lauroyl-CoA
mitochondrial fatty acid beta-oxidation of unsaturated fatty acids
Beta oxidation of palmitoyl-CoA to myristoyl-CoA
Beta oxidation of lauroyl-CoA to decanoyl-CoA-CoA
Beta oxidation of decanoyl-CoA to octanoyl-CoA-CoA
Beta oxidation of octanoyl-CoA to hexanoyl-CoA
Beta oxidation of hexanoyl-CoA to butanoyl-CoA


Phenotype (from MGI, Zfin or HPO)
IDPhenotypeDefinition Genetic BG
 HP:0000007 Autosomal recessive inheritance "A mode of inheritance that is observed for traits related to a gene encoded on one of the autosomes (i.e., the human chromosomes 1-22) in which a trait manifests in homozygotes. In the context of medical genetics, autosomal recessive disorders manifest in homozygotes (with two copies of the mutant allele) or compound heterozygotes (whereby each copy of a gene has a distinct mutant allele)." [HPO:curators]
Show

 HP:0000488 Retinopathy 
Show

 HP:0000512 Abnormal electroretinogram "Any abnormality of the electrical responses of various cell types in the retina as measured by electroretinography." [HPO:curators]
Show

 HP:0000533 Chorioretinal atrophy 
Show

 HP:0000545 Myopia 
Show

 HP:0000572 Visual loss 
Show

 HP:0000577 Exotropia 
Show

 HP:0000580 Pigmentary retinopathy 
Show

 HP:0000613 Photophobia "Excessive sensitivity to light with the sensation of discomfort or pain in the eyes due to exposure to bright light." [HPO:curators]
Show

 HP:0000662 Night blindness 
Show

 HP:0001249 Mental retardation 
Show

 HP:0001250 Seizures "Seizures are an intermittent `abnormality of the central nervous system` (FMA:HP:0002011) due to a sudden, excessive, disorderly discharge of cerebral neurons and characterized clinically by some combination of disturbance of sensation, loss of consciousness, impairment of psychic function, or convulsive movements." [HPO:probinson]
Show

 HP:0001252 Muscular hypotonia "Muscular hypotonia is an abnormally low muscle tone (the amount of tension or resistance to movement in a muscle), often involving reduced muscle strength. Hypotonia is characterized by a diminished resistance to passive stretching." [HPO:curators]
Show

 HP:0001263 Developmental retardation "A delay in the achievement of motor or mental milestones manifested prior to age 18 and generally associated with lifelong mental and/or physical impairments." [HPO:curators]
Show

 HP:0001290 Generalized hypotonia "Generalized muscular hypotonia (abnormally low muscle tone)." [HPO:curators]
Show

 HP:0001508 Failure to thrive 
Show

 HP:0001518 Low birth weight 
Show

 HP:0001560 Abnormality of the amniotic fluid "Abnormality of the amniotic fluid, which is the fluid contained in the amniotic sac surrounding the developing fetus." [HPO:curators]
Show

 HP:0001635 Congestive heart failure "The presence of an abnormality of cardiac function that is responsible for the failure of the heart to pump blood at a rate that is commensurate with the needs of the tissues or a state in which abnormally elevated filling pressures are required for the heart to do so. Heart failure is frequently related to a defect in myocardial contraction." [HPO:curators]
Show

 HP:0001638 Cardiomyopathy 
Show

 HP:0001639 Hypertrophic cardiomyopathy 
Show

 HP:0001644 Dilated cardiomyopathy 
Show

 HP:0001699 Sudden death 
Show

 HP:0001789 Hydrops fetalis 
Show

 HP:0001943 Hypoglycemia "A lower than normal level of blood glucose." [HPO:curators]
Show

 HP:0001985 Hypoketotic hypoglycemia 
Show

 HP:0001987 Hyperammonemia 
Show

 HP:0002093 Respiratory insufficiency 
Show

 HP:0002240 Hepatomegaly "An abnormal enlargment of the liver." [HPO:curators]
Show

 HP:0002611 Cholestatic liver disease 
Show

 HP:0002686 Prenatal maternal abnormality 
Show

 HP:0002878 Early respiratory failure 
Show

 HP:0002910 Elevated transaminases "Elevations of the levels of SGOT and SGPT in the serum. SGOT (serum glutamic oxaloacetic transaminase) and SGPT (serum glutamic pyruvic transaminase) are transaminases primarily found in the liver and heart and are released into the bloodstream as the result of liver or heart damage. SGOT and SGPT are used clinically mainly as markers of liver damage." [HPO:curators]
Show

 HP:0002913 Myoglobinuria 
Show

 HP:0003128 Lactic acidemia "An abnormal buildup of `lactic acid` (CHEBI:28358) in the body, leading to `acidification` (GO:0045851) of the blood." [HPO:probinson]
Show

 HP:0003201 Rhabdomyolysis 
Show

 HP:0003324 Generalized muscle weakness "Generalized weakness or decreased strength of the muscles." [HPO:curators]
Show

 HP:0003326 Myalgia "A tendency to experience muscle pain." [HPO:curators]
Show

 HP:0007703 Abnormal retinal pigmentation 
Show

 HP:0009830 Peripheral neuropathy "Peripheral neuropathy is a general term for any disorder of the peripheral nervous system. The main clinical features used to classify peripheral neuropathy are distribution, type (mainly demyelinating versus mainly axonal), duration, and course." [HPO:curators]
Show

 HP:0011968 Feeding difficulties "Impaired ability to eat related to problems gathering food and getting ready to suck, chew, or swallow it." [ISCA:eriggs]
Show

 HP:0030856 Posterior staphyloma "A localized defect in the posterior eye wall with protrusion of uveal tissue due to alterations in scleral thickness and structure." [HPO:probinson, PMID:25376120]
Show

 HP:0100950 Long chain 3 hydroxyacyl coA dehydrogenase deficiency 
Show

  


Interacting proteins (from Reactome)
Interactor ID Name Interaction type
 ENSG00000138029 HADHB / P55084 / hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit beta  / complex
 ENSG00000084754 HADHA / P40939 / hydroxyacyl-CoA dehydrogenase trifunctional multienzyme complex subunit alpha  / complex






 

0 s.

 
External programs and data are copyrighted by and are the property of their respective authors.
The Manteia system, data and analyses are provided "as is" with no warranties, expressed or implied as to capabilities or accuracy. User assumes the entire risk as to the results and performance of the software, data and documentation


                   


© Olivier Tassy / Olivier Pourquie 2007-2024
contact: otassy@igbmc.fr